|
|
HEADLINES
EuropaBio and Smithers Rapra, in association with IAR, unveil the agenda for the European Forum for Industrial Biotechnology (EFIB) from 1-2 October 2014 taking place in the heart of Champagne-Ardenne, France
This year's event, which takes place during the week preceding European Biotech Week, includes a high level plenary with French ministerial address, and European Commission officials debating about the future evolution of the European biobased economy. These insights will be followed by discussions chaired by Ian Hudson, President EMEA DuPont de Nemours International, featuring representatives from Shell and European Bioplastics.
Read more
Apply now for the 5th Annual EuropaBio Most Innovative EU Biotech SME Award!
EuropaBio is calling on the best biotech SMEs in Europe to apply for the Most Innovative EU Biotech SME award until the 01st of July. Now in its 5th year, the award rewards European SMEs who have developed novel ways of meeting societal, technical and environmental issues through the application of biotechnology.
Read more
Don't misinterpret the results of the Swiss referendum
During the Swiss Biotech Day in Zurich, Swiss Biotech Association presented its 2014 report highlighting the most important innovation drivers in the country's industry and the impact of biotech on our lives. With the EC recently suspending Switzerland from Horizon 2020, preserving the innovative power of this research-intensive sector is vital to keeping the industry moving forward. Read more
The melanoma trial of the future
A recent documentary of the m-icab/ESO conference (28th-30th March, Brussels) on patient participation in clinical research shows important support on melanoma patients exploring innovative drug development concepts better suited to patients' needs. Read more
|
|
|
|
Healthcare Biotech
New NHS boss: service must become world leader in personalised medicine
There is a need to focus on a "global medical revolution" that would hold out the prospect of patients having a better chance of overcoming diseases such as cancer, said Simon Stevens, the chief executive of NHS England, urging the service to become world leader in personalised medicine using a patient's genetic profile to devise better treatments. Read more
Stem cell therapies look promising for heart disease, says new research
Taking stem cells from a patient's bone marrow and injecting them into their damaged heart may be an effective way to treat heart disease, shows new research conducted by the Cochrane research group, based in Oxford, UK. Read more |
|
Agricultural Biotech
Seeking approval: the challenge with biotech crops in the EU
The delay is twice as long to have something approved in Europe compared to the US; it takes an average of four years in the EU to approve GM products for import, while the US is aiming at 1.5 years. And this leads to costly trade disruptions, said Nilsy Desaint, Public Affairs and Communications Manager for Green Biotech Europe, unit of EuropaBio. Read more
Looking for common ground in Europe
With extremely wide differences remaining between EU member states, with governments, like that of Britain, bemoaning the loss of potential technology investment, while others, like France and Austria, trying to block GM crops, Europe needs to seek common ground and settle disputes. Read more
Would consumers buy transgenic food if they believed it would boost health?
New scientific paper issued by Kansas State University scientists studied the consumer acceptance of transgenic tomatoes, showing that 96% of respondents would purchase and consume transgenic foods. Read more |
|
Industrial Biotech
How biomass power creates fuel from waste
Richard Spinks, Chief Executive Officer at Active Energy, speaks in a Bloomberg video interview about the growing demand for biomass and the process of producing power out of trees. Read more
Bioserie introduces "Made of Plants" Toys for Babies
This week, Bioserie launched a line of bioplastic baby toys completely free of oil-based chemicals. The bioplastics technology reduces considerably the amount of greenhouse gas emissions and prevents the use of harmful substances such as BPA, PVC, Phthalates, Styrenes and heavy metals.
Read more |
|
|
|
|
SMEs
External Stakeholder Meeting: How can the European IPR Helpdesk assist SMEs and researchers in Horizon 2020?
The online webinar will take place on the 18th of June, focusing on the new Framework Programme: Horizon 2020. It is meant to be an initiative funded by the DG Enterprise and Industry of the European Commission under the Competitiveness and Innovation Framework Programme and managed by the Executive Agency for Small and Medium-sized Enterprises. Read more
Lack of funding prevents companies from capitalising on their innovations
The 2014 Innobarometer survey on "The role of public support in the commercialisation of innovations" reports that access to finance remains the main obstacle to innovation encountered by companies in the commercialisation of their products or services.
Read more
|
|
EVENTS
- 05-06 June: BIOVISION, Lyon, France. More information
- 23-26 June: BIO International Convention, San Diego, USA. More information
- 09-10 July: 3rd European Biorefinery Traning School , Budapest, Hungary. More information
- 13-17 July, 16th European Congress on Biotechnology, Edinburgh, Scotland. More information
- 20 September: EPDA European Unity Walk 2014, Luxembourg. More information
- 24-26 September, BIOSPAIN - 7th International Meeting on Biotechnology, Santiago de Compostela, Spain. More information
- 30 September-2 October, EFIB - European Forum for Industrial Biotechnology & The Biobased Economy, Reims, France. More information
- 15-17 October, BioJapan 2014, Yokohama, Japan. More information
- 18-20 November, Food Matters Live, London, UK. More information
- 02-03 December, BioFIT 2014, Lille, France. More information
|
|
|
|
|
|
|
|
